Figure 4. Time to parasitemia in vaccinees and controls participating in CHMI as assessed by qPCR.
All 5 HIV– vaccinees received 9.0 × 105 PfSPZ on days 1, 3, 5, 7, and 29. Three HIV+ vaccinees received 9.0 × 105 PfSPZ on days 1, 3, 5, 7, and 29; 1 HIV+ vaccinee received 9.0 × 105 PfSPZ on days 1, 3, 7, and 29. Three weeks after the last vaccination, participants underwent homologous CHMI.